Evidence map›Paper›PMID 34711957›Full record

ArticleNature genetics2021

An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci.

Edward Mountjoy, Ellen M Schmidt, Miguel Carmona, Jeremy Schwartzentruber, Gareth Peat, Alfredo Miranda, Luca Fumis, James Hayhurst, Annalisa Buniello, Mohd Anisul Karim and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Nature genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 367 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
367citing papers in PubMed, 14 pooled it
82.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

367 citing papers in PubMed, 14 syntheses or guidelines pooled it, 616 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

307 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Edward MountjoyWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-0626-1821
Ellen M SchmidtWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Miguel CarmonaOpen Targets, Wellcome Genome Campus, Hinxton, UK.
Jeremy SchwartzentruberWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-6183-2092
Gareth PeatOpen Targets, Wellcome Genome Campus, Hinxton, UK.
Alfredo MirandaOpen Targets, Wellcome Genome Campus, Hinxton, UK.
Luca FumisOpen Targets, Wellcome Genome Campus, Hinxton, UK.
James HayhurstOpen Targets, Wellcome Genome Campus, Hinxton, UK.
Annalisa BunielloOpen Targets, Wellcome Genome Campus, Hinxton, UK.
Mohd Anisul KarimWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Daniel WrightWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Andrew HerculesOpen Targets, Wellcome Genome Campus, Hinxton, UK.
Eliseo PapaSystems Biology, Biogen, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-2467-7759
Eric B FaumanIntegrative Biology, Internal Medicine Research Unit, Pfizer Worldwide Research, Development and Medical, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-9739-0249
Jeffrey C BarrettWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
John A ToddWellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-2740-8148
David OchoaOpen Targets, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0003-1857-278X
Ian DunhamWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0003-2525-5598
Maya GhoussainiWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. maya.ghoussaini@sanger.ac.uk.ORCID http://orcid.org/0000-0002-2415-2143
European Bioinformatics Institute · GBWellcome Sanger Institute · GBBiogen (United States) · USCentre for Human Genetics · GBPfizer (United States) · US

Funding

Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Wellcome Trust 206194
6 · The paper itself

Abstract

Genome-wide association studies (GWASs) have identified many variants associated with complex traits, but identifying the causal gene(s) is a major challenge. In the present study, we present an open resource that provides systematic fine mapping and gene prioritization across 133,441 published human GWAS loci. We integrate genetics (GWAS Catalog and UK Biobank) with transcriptomic, proteomic and epigenomic data, including systematic disease-disease and disease-molecular trait colocalization results across 92 cell types and tissues. We identify 729 loci fine mapped to a single-coding causal variant and colocalized with a single gene. We trained a machine-learning model using the fine-mapped genetics and functional genomics data and 445 gold-standard curated GWAS loci to distinguish causal genes from neighboring genes, outperforming a naive distance-based model. Our prioritized genes were enriched for known approved drug targets (odds ratio = 8.1, 95% confidence interval = 5.7, 11.5). These results are publicly available through a web portal ( http://genetics.opentargets.org ), enabling users to easily prioritize genes at disease-associated loci and assess their potential as drug targets.

Indexed as

Genome-Wide Association StudyModels, GeneticChromosome MappingEpigenomicsGenomicsHumansMachine LearningPolymorphism, Single NucleotideQuantitative Trait Loci

Identifiers

PMID34711957
PMCPMC7611956
OpenAlexW3210601686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.